4.7 Letter

Detection of distinct MERS-Coronavirus strains in dromedary camels from Kenya, 2017

Journal

EMERGING MICROBES & INFECTIONS
Volume 7, Issue -, Pages -

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1038/s41426-018-0193-z

Keywords

-

Funding

  1. Food and Agriculture Organization of the United Nations project - United States Agency for International Development (USAID) [OSRO/GLO/505/USA]
  2. Centre for International Migration and Development, Germany [81195004]
  3. EU [115760, 643476]

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Multidisciplinary Sciences

SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies

S. Momsen Reincke, Meng Yuan, Hans-Christian Kornau, Victor M. Corman, Scott van Hoof, Elisa Sanchez-Sendin, Melanie Ramberger, Wenli Yu, Yuanzi Hua, Henry Tien, Marie Luisa Schmidt, Tatjana Schwarz, Lara Maria Jeworowski, Sarah E. Brandl, Helle Foverskov Rasmussen, Marie A. Homeyer, Laura Stoffler, Martin Barner, Desiree Kunkel, Shufan Huo, Johannes Horler, Niels von Wardenburg, Inge Kroidl, Tabea M. Eser, Andreas Wieser, Christof Geldmacher, Michael Hoelscher, Hannes Ganzer, Gunter Weiss, Dietmar Schmitz, Christian Drosten, Harald Pruss, Ian A. Wilson, Jakob Kreye

Summary: The Beta variant of concern (VOC) of SARS-CoV-2 shows resistance to neutralization by antibodies from COVID-19 patients and vaccinated individuals. Researchers have identified specific antibodies in serum from Beta-infected patients that are able to cross-react with the wild type virus. This finding provides insights into the antibody response to antigenic drift and has implications for the development of future vaccines and therapeutics.

SCIENCE (2022)

Article Infectious Diseases

Monkeypox in-patients with severe anal pain

Frieder Pfafflin, Daniel Wendisch, Roland Scherer, Linda Juergens, Gisele Godzick-Njomgang, Eva Tranter, Pinkus Tober-Lau, Miriam Songa Stegemann, Victor Max Corman, Florian Kurth, Dirk Schuermann

Summary: This study reports the clinical characteristics of the first confirmed monkeypox patients admitted to a center in Berlin. Among the patients, most were MSM who had engaged in condomless receptive anal intercourse prior to admission. The main complaint was severe anal pain, and investigations revealed proctitis and anal and rectal ulcers with detection of the monkeypox virus. These findings suggest that sexual transmission may play a role in the current outbreak.

INFECTION (2023)

Letter Medicine, General & Internal

Drug Sensitivity of Currently Circulating Mpox Viruses

Denisa Bojkova, Marco Bechtel, Tamara Rothenburger, Katja Steinhorst, Nadja Zoeller, Stefan Kippenberger, Julia Schneider, Victor M. Corman, Hannah Uri, Mark N. Wass, Gaby Knecht, Pavel Khaykin, Timo Wolf, Sandra Ciesek, Holger F. Rabenau, Martin Michaelis, Jindrich Cinatl

Summary: In vitro, the Mpox isolates from 12 patients with mpox virus infection showed sensitivity to the antiviral agents tecovirimat, cidofovir, and brincidofovir at clinically achievable levels.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

Article Public, Environmental & Occupational Health

Establishment of genomic pathogen surveillance to strengthen pandemic preparedness and infection prevention in Germany

Simone Scheithauer, Alexander Dilthey, Anna Bludau, Sandra Ciesek, Victor Corman, Tjibbe Donker, Tim Eckmanns, Richard Egelkamp, Hajo Grundmann, Georg Haecker, Martin Kaase, Berit Lange, Alexander Mellmann, Martin Mielke, Mathias Pletz, Bernd Salzberger, Andrea Thuermer, Andreas Widmer, Lothar H. Wieler, Thorsten Wolff, Soeren Gatermann, Torsten Semmler

Summary: The deficit of genomic pathogen surveillance infrastructure in Germany has been revealed during the SARS-CoV-2 pandemic. Establishing an efficient and adaptable genomic pathogen surveillance network is urgently needed to prepare for future pandemics. This paper proposes measures based on global and country-specific best practices to achieve integrated genomic pathogen surveillance, which includes linking epidemiological data with pathogen genomic data, sharing and coordinating resources, making surveillance data available to decision-makers, public health service, and the scientific community, and engaging all stakeholders.

BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ (2023)

Article Biochemistry & Molecular Biology

MHC class II genes mediate susceptibility and resistance to coronavirus infections in bats

Dominik W. Schmid, Magdalena Meyer, Kerstin Wilhelm, Tatiana Tilley, Thomas Link-Hessing, Ramona Fleischer, Ebenezer K. Badu, Evans Ewald Nkrumah, Samuel Kingsley Oppong, Nina Schwensow, Marco Tschapka, Heather J. Baldwin, Peter Vallo, Victor M. Corman, Christian Drosten, Simone Sommer

Summary: Understanding the immunogenetic basis of coronavirus susceptibility in major pathogen reservoirs, such as bats, is crucial for inferring their zoonotic potential.

MOLECULAR ECOLOGY (2023)

Article Clinical Neurology

Humoral immune responses remain quantitatively impaired but improve qualitatively in anti-CD20-treated patients with multiple sclerosis after three or four COVID-19 vaccinations

Carolin Otto, Tatjana Schwarz, Lara M. Jeworowski, Marie L. Schmidt, Felix Walper, Florence Pache, Patrick Schindler, Moritz Niederschweiberer, Andi Krumbholz, Ruben Rose, Christian Drosten, Klemens Ruprecht, Victor M. Corman

Summary: The study aimed to analyze the levels of anti-SARS-CoV-2-S1-IgG, avidity, Omicron BA.2 variant neutralizing capacity, and SARS-CoV-2-specific T cells in anti-CD20-treated patients with multiple sclerosis (aCD20pwMS) after two, three, or four COVID-19 vaccinations. The results showed that the frequencies of aCD20pwMS with detectable SARS-CoV-2-S1-IgG increased moderately between two, three, and four vaccinations. However, the frequencies of high avidity and Omicron neutralizing antibodies increased strongly between two and four vaccinations among patients with detectable SARS-CoV-2-S1-IgG. SARS-CoV-2-specific T cells were detectable in more than 92% of the patients after two or more vaccinations.

MULTIPLE SCLEROSIS JOURNAL (2023)

Article Multidisciplinary Sciences

Distinct tissue niches direct lung immunopathology via CCL18 and CCL21 in severe COVID-19

Ronja Mothes, Anna Pascual-Reguant, Ralf Koehler, Juliane Liebeskind, Alina Liebheit, Sandy Bauherr, Lars Philipsen, Carsten Dittmayer, Michael Laue, Regina von Manitius, Sefer Elezkurtaj, Pawel Durek, Frederik Heinrich, Gitta A. Heinz, Gabriela M. Guerra, Benedikt Obermayer, Jenny Meinhardt, Jana Ihlow, Josefine Radke, Frank L. Heppner, Philipp Enghard, Helena Stockmann, Tom Aschman, Julia Schneider, Victor M. Corman, Leif E. Sander, Mir-Farzin Mashreghi, Thomas Conrad, Andreas C. Hocke, Raluca A. Niesner, Helena Radbruch, Anja E. Hauser

Summary: Inflammation, lung pathology, and development of COVID-19 are associated with SARS-CoV-2 infection. This study demonstrates the spatial association of CCL18 and CCL21 with lung pathology in severe COVID-19. The activation of adventitial niches plays a crucial role in the prolonged lung immunopathology observed in severe COVID-19.

NATURE COMMUNICATIONS (2023)

Article Medicine, General & Internal

RECAST: Study protocol for an observational study for the understanding of the increased REsilience of Children compared to Adults in SARS-CoV-2 infecTion

Sebastian Stricker, Niklas Ziegahn, Martin Karsten, Thomas Boeckel, Heike Stich-Boeckel, Jakob Maske, Evelyn Rugo, Anita Balazs, Pamela Millar Buchner, Chantip Dang-Heine, Valentin Schriever, Roland Eils, Irina Lehmann, Leif E. Sander, Markus Ralser, Victor M. Corman, Marcus A. Mall, Birgit Sawitzki, Jobst Roehmel

Summary: This study aims to characterize age-dependent differences in immune responses to respiratory infections, using SARS-CoV-2 as a model virus, and assess age differences in clinical outcomes, including lung function. The study plans to recruit at least 120 children and 60 adults infected with SARS-CoV-2 and collect specimens for multiomics analysis. The data obtained from this study will be correlated with medical history and clinical data.

BMJ OPEN (2023)

Article Microbiology

Monitoring the SARS-CoV-2 Pandemic: Prevalence of Antibodies in a Large, Repetitive Cross-Sectional Study of Blood Donors in Germany-Results from the SeBluCo Study 2020-2022

Ruth Offergeld, Karina Preussel, Thomas Zeiler, Konstanze Aurich, Barbara I. Baumann-Baretti, Sandra Ciesek, Victor M. Corman, Viktoria Dienst, Christian Drosten, Siegfried Goerg, Andreas Greinacher, Marica Grossegesse, Sebastian Haller, Hans-Gert Heuft, Natalie Hofmann, Peter A. Horn, Claudia Houareau, Ilay Guelec, Carlos Luis Jimenez Klingberg, David Juhl, Monika Lindemann, Silke Martin, Hannelore K. Neuhauser, Andreas Nitsche, Julia Ohme, Sven Peine, Ulrich J. Sachs, Lars Schaade, Richard Schaefer, Heinrich Scheiblauer, Martin Schlaud, Michael Schmidt, Markus Umhau, Tanja Vollmer, Franz F. Wagner, Lothar H. Wieler, Hendrik Wilking, Malte Ziemann, Marlow Zimmermann, Matthias an der Heiden

Summary: SARS-CoV-2 serosurveillance is crucial for infection control measures and understanding underreporting. A study in Germany analyzed blood donor samples collected from April 2020 to April 2021, September 2021, and April/May 2022. The seroprevalence of SARS-CoV-2 increased over time, reaching 100% in April/May 2022. Neutralizing capacity was also observed in the majority of positive specimens. The study revealed low levels of underreporting, indicating an effective testing and notification system in Germany.

PATHOGENS (2023)

Article Public, Environmental & Occupational Health

Seropositivity and flight-associated risk factors for SARS-CoV-2 infection among asylum seekers arriving in Berlin, Germany - a cross-sectional study

Ariadne Brandt, Lena Breucker, Jan Keller, Victor Max Corman, Norma Bethke, Joachim Seybold

Summary: This study investigated the infection status and living conditions of adult asylum seekers arriving in Berlin, and found that precarious living conditions during flight increased the risk of SARS-CoV-2 infection. Factors associated with infection included gender, hygiene behaviors, and travel mode. Public health interventions should be implemented to address these risks.

FRONTIERS IN PUBLIC HEALTH (2023)

Article Multidisciplinary Sciences

Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the sotrovimab face but is escaped by Omicron

Jakob Kreye, S. Momsen Reincke, Stefan Edelburg, Lara M. Jeworowski, Hans-Christian Kornau, Jakob Trimpert, Peter Hombach, Sophia Halbe, Volker Noelle, Martin Meyer, Stefanie Kattenbach, Elisa Sanchez-Sendin, Marie L. Schmidt, Tatjana Schwarz, Ruben Rose, Andi Krumbholz, Sophie Merz, Julia M. Adler, Kathrin Eschke, Azza Abdelgawad, Dietmar Schmitz, Leif E. Sander, Uwe Janssen, Victor M. Corman, Harald Pruess

Summary: The emergence of novel viral variants of concern (VOCs) that evade preexisting antibody immunity poses a continuous challenge for developing updated therapies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In this study, the patient-derived antibody CV38-142 was selected for preclinical development as a therapeutic due to its potency and breadth against multiple VOCs. CV38-142 demonstrated efficacy in vivo against VOC infection in a Syrian hamster model and showed favorable safety characteristics in human protein library screening and tissue cross-reactivity analysis. However, it did not neutralize the Omicron lineages BA.1 and BA.2, underscoring the need for developing broadly neutralizing variant-proof antibodies against SARS-CoV-2.

ISCIENCE (2023)

Article Biochemistry & Molecular Biology

ORF3c is expressed in SARS-CoV-2-infected cells and inhibits innate sensing by targeting MAVS

Martin Mueller, Alexandra Herrmann, Shigeru Fujita, Keiya Uriu, Carolin Kruth, Adam Strange, Jan E. Kolberg, Markus Schneider, Jumpei Ito, Marcel A. Mueller, Christian Drosten, Armin Ensser, Kei Sato, Daniel Sauter

Summary: In this study, we identify ORF3c of SARS-CoV-2 as an immune evasion factor that suppresses innate sensing in infected cells by interact with the signaling adaptor MAVS.

EMBO REPORTS (2023)

Article Microbiology

Pharmacological inhibition of bromodomain and extra-terminal proteins induces an NRF-2-mediated antiviral state that is subverted by SARS-CoV-2 infection

Baxolele Mhlekude, Dylan Postmus, Saskia Stenzel, January Weiner, Jenny Jansen, Francisco J. Zapatero-Belinchon, Ruth Olmer, Anja Richter, Julian Heinze, Nicolas Heinemann, Barbara Muehlemann, Simon Schroeder, Terry C. Jones, Marcel A. Mueller, Christian Drosten, Andreas Pich, Volker Thiel, Ulrich Martin, Daniela Niemeyer, Gisa Gerold, Dieter Beule, Christine Goffinet

Summary: JQ-1 exhibits anti-SARS-CoV-2 activity by downregulating ACE2 expression and inducing NRF-2-mediated cytoprotective response, but this activity is gradually subverted by the virus. Therapeutic administration of JQ-1 does not inhibit SARS-CoV-2 replication.

PLOS PATHOGENS (2023)

Article Medicine, Research & Experimental

90K/LGALS3BP expression is upregulated in COVID-19 but may not restrict SARS-CoV-2 infection

Laure Bosquillon de Jarcy, Bengisu Akbil, Baxolele Mhlekude, Johanna Leyens, Dylan Postmus, Greta Harnisch, Jenny Jansen, Marie L. Schmidt, Annette Aigner, Fabian Pott, Robert Lorenz Chua, Lilian Krist, Roberta Gentile, Barbara Muehlemann, Terence C. Jones, Daniela Niemeyer, Julia Fricke, Thomas Keil, Tobias Pischon, Juergen Janke, Christian Conrad, Stefano Iacobelli, Christian Drosten, Victor M. Corman, Markus Ralser, Roland Eils, Florian Kurth, Leif Sander, Christine Goffinet

Summary: The expression levels of 90K/LGALS3BP protein were found to be elevated in COVID-19 patients. The SARS-CoV-2 infection inhibited the levels of PBMC-associated 90K protein, suggesting increased release into the extracellular space. Monocyte-specific induction of LGALS3BP mRNA expression was also observed in COVID-19 patients.

CLINICAL AND EXPERIMENTAL MEDICINE (2023)

Article Virology

Non-structural genes of novel lemur adenoviruses reveal codivergence of virus and host

Talitha Veith, Tobias Bleicker, Monika Eschbach-Bludau, Sebastian Bruenink, Barbara Muehlemann, Julia Schneider, Joern Beheim-Schwarzbach, S. Jacques Rakotondranary, Yedidya R. Ratovonamana, Cedric Tsagnangara, Refaly Ernest, Faly Randriantafika, Simone Sommer, Nadine Stetter, Terry C. Jones, Christian Drosten, Joerg U. Ganzhorn, Victor M. Corman

Summary: A new adenovirus species was discovered in Madagascan lemurs, which has a particularly large gene encoding a protein with unknown function. Surprisingly, this new adenovirus is most similar to bat adenovirus C, rather than human or other simian adenoviruses. The study suggests a coevolution between the virus and lemur hosts, involving both a host switch and codivergence.

VIRUS EVOLUTION (2023)

No Data Available